Brief: Avrobio Reports Q1 2023 Financial Results And Provides Business Update

Tectonic Therapeutic

11/05/2023 13:47

May 11 (Reuters) - Avrobio Inc  AVRO.O :
    * AVROBIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
    * AVROBIO - ON TRACK TO INITIATE REGISTRATIONAL GLOBAL PHASE
2/3
CLINICAL TRIAL FOR GAUCHER DISEASE TYPE 3 IN SECOND HALF 2023
    * AS OF MARCH 31, 2023, HAD $72.3 MILLION IN CASH AND CASH
EQUIVALENTS
    * AVROBIO - QTRLY NET LOSS PER SHARE $0.57
    * Q1 EARNINGS PER SHARE VIEW $-0.55 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw5hS6bPa 
Further company coverage:  AVRO.O 

 ((Reuters.Briefs@thomsonreuters.com;))